These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 34749048)

  • 1. Vascular endothelial growth factor (VEGF) and hypoxia inducible factor-1 alpha (HIF-1ɑ) in lacrimal gland Adenoid cystic carcinoma: Correlation with clinical outcome.
    Anjum S; Sen S; Chosdol K; Bakhshi S; Kashyap S; Pushker N; Bajaj MS; Meel R; Sharma MC
    Ann Diagn Pathol; 2022 Feb; 56():151846. PubMed ID: 34749048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of Notch1 receptor and clinicopathological High-Risk Predictors in lacrimal gland adenoid cystic carcinoma.
    Anjum S; Sen S; Pushker N; Bajaj MS; Kashyap S; Bakhshi S; Chosdol K; Meel R; Sharma MC
    Acta Ophthalmol; 2021 Dec; 99(8):e1467-e1473. PubMed ID: 33675181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levels and patterns of expression of hypoxia-inducible factor-1α, vascular endothelial growth factor, glucose transporter-1 and CD105 in adenoid cystic carcinomas with high-grade transformation.
    Costa AF; Tasso MG; Mariano FV; Soares AB; Chone CT; Crespo AN; Fresno MF; Llorente JL; Suárez C; de Araújo VC; Hermsen M; Altemani A
    Histopathology; 2012 Apr; 60(5):816-25. PubMed ID: 22320429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Impact of Notch1 Intracellular Domain, P63, and c-MYC in Lacrimal Gland Adenoid Cystic Carcinoma.
    Zhao J; Williams MD; Hernandez M; Kuang G; Goldberg H; Fan J; Ning J; Ferrarotto R; Esmaeli B
    Invest Ophthalmol Vis Sci; 2024 Sep; 65(11):4. PubMed ID: 39230995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of metabolism-related proteins in lacrimal gland adenoid cystic carcinoma.
    Koo JS; Yoon JS
    Am J Clin Pathol; 2015 Apr; 143(4):584-92. PubMed ID: 25780012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival outcomes of eye-sparing surgery for adenoid cystic carcinoma of lacrimal gland.
    Hung JY; Wei YH; Huang CH; Chen LW; Fuh CS; Liao SL
    Jpn J Ophthalmol; 2019 Jul; 63(4):344-351. PubMed ID: 31134459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The expression of MMP-2 and MMP-9 in adenoid cystic carcinoma of lacrimal gland].
    Zhang L; Zhang H; Song GX; Lin TT; Xu GC; Zhu LM
    Zhonghua Yan Ke Za Zhi; 2013 Jan; 49(1):58-63. PubMed ID: 23601468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenoid cystic carcinoma of the lacrimal gland is frequently characterized by MYB rearrangement.
    Chen TY; Keeney MG; Chintakuntlawar AV; Knutson DL; Kloft-Nelson S; Greipp PT; Garrity JA; Salomao DR; Garcia JJ
    Eye (Lond); 2017 May; 31(5):720-725. PubMed ID: 28085142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors for local recurrence and survival and impact of local treatments on survival in lacrimal gland carcinoma.
    Ford JR; Rubin ML; Frank SJ; Ning J; Debnam JM; Bell D; El-Naggar A; Ferrarotto R; Esmaeli B
    Br J Ophthalmol; 2021 Jun; 105(6):768-774. PubMed ID: 32680839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Outcomes of Eye-Sparing Surgery for Adenoid Cystic Carcinoma of Lacrimal Gland.
    Han J; Kim YD; Woo KI; Sobti D
    Ophthalmic Plast Reconstr Surg; 2018; 34(1):74-78. PubMed ID: 28221296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodal therapy in the management of lacrimal gland adenoid cystic carcinoma.
    Yang J; Zhou C; Wang Y; Fan X; Jia R
    BMC Ophthalmol; 2019 Jun; 19(1):125. PubMed ID: 31176360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostic value of the expression of vascular endothelial growth factor A and hypoxia-inducible factor 1alpha in patients undergoing surgery for non-small cell lung cancer].
    Honguero Martínez AF; Arnau Obrer A; Figueroa Almazán S; Martínez Hernández N; Guijarro Jorge R
    Med Clin (Barc); 2014 May; 142(10):432-7. PubMed ID: 23948151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of hypoxia inducible factor 1alpha mRNA is associated with elevated vascular endothelial growth factor expression and excessive angiogenesis and predicts a poor prognosis in gastric carcinoma.
    Ma J; Zhang L; Ru GQ; Zhao ZS; Xu WJ
    World J Gastroenterol; 2007 Mar; 13(11):1680-6. PubMed ID: 17461470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lacrimal Gland Adenocarcinoma Clinicopathologic Features and Outcomes Compared With Those of Lacrimal Gland Adenoid Cystic Carcinoma.
    Goldberg H; Jiang X; Fan J; Zhao J; Ning J; Williams M; Frank S; Moreno A; Gunn B; Ferrarotto R; Esmaeli B
    Ophthalmic Plast Reconstr Surg; 2024 Jul-Aug 01; 40(4):419-425. PubMed ID: 38319188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Autophagy and Reactive Oxygen Species-Related Proteins in Lacrimal Gland Adenoid Cystic Carcinoma.
    Koo JS; Kim JW; Yoon JS
    Yonsei Med J; 2016 Mar; 57(2):482-9. PubMed ID: 26847304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of hypoxia-inducible factor 1α, and its correlation with p53 and vascular endothelial growth factor expression in resectable esophageal squamous cell carcinoma.
    Shao N; Han Y; Song L; Song W
    J Cancer Res Ther; 2020; 16(2):269-275. PubMed ID: 32474512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of expression of molecular markers in adenoid cystic cancer of the salivary glands compared with lymph node metastasis: a retrospective study.
    Lee SK; Kwon MS; Lee YS; Choi SH; Kim SY; Cho KJ; Nam SY
    World J Surg Oncol; 2012 Dec; 10():266. PubMed ID: 23231994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenoid Cystic Carcinoma from the salivary and lacrimal glands and the breast: Different clinical outcomes to the same tumor.
    Emerick C; Mariano FV; Vargas PA; Nör JE; Squarize CH; Castilho RM
    Crit Rev Oncol Hematol; 2022 Nov; 179():103792. PubMed ID: 35973662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor, hypoxia-inducible factor 1 alpha and CD34 expressions in early-stage gastric tumors: relationship with pathological factors and prognostic impact on survival.
    Cabuk D; Basaran G; Celikel C; Dane F; Yumuk PF; Iyikesici MS; Ekenel M; Turhal NS
    Oncology; 2007; 72(1-2):111-7. PubMed ID: 18025805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic role of tumor necrosis, microvessel density, vascular endothelial growth factor and hypoxia inducible factor-1alpha in patients with clear cell renal carcinoma after radical nephrectomy in a long term follow-up.
    Minardi D; Lucarini G; Filosa A; Milanese G; Zizzi A; Di Primio R; Montironi R; Muzzonigro G
    Int J Immunopathol Pharmacol; 2008; 21(2):447-55. PubMed ID: 18547492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.